Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Helex septal occluder"'
Publikováno v:
Journal of the Saudi Heart Association, Vol 28, Iss 3, Pp 167-169 (2016)
We report a case of a 38-year-old-man who presented with altered mental status. The patient was diagnosed with infective endocarditis (IE) originating from the GORE HELEX septal occluder device, which was placed 15 months earlier for symptomatic atri
Externí odkaz:
https://doaj.org/article/c7128470b4ef4902bed08e719f1308b9
Autor:
Pedra Carlos A.C., Pedra Simone F., Esteves César A., Chamiê Francisco, Ramos Sérgio, Pontes Jr Sérgio C., Tress João Carlos, Braga Sérgio L. N., Latson Larry A., Fontes Valmir F.
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 81, Iss 5, Pp 444-452 (2003)
OBJECTIVE: To evaluate the initial clinical experience with the Helex septal occluder for percutaneous closure of atrial septal defects. METHODS: Ten patients underwent the procedure, 7 patients with ostium secundum atrial septal defects (ASD) with h
Externí odkaz:
https://doaj.org/article/10ccb6cdfa104e1c996655268c72284b
Autor:
Michael P. Cinquegrani, Harshal Patil, Noelle C. Garster, Lyle D. Joyce, Sudhi Tyagi, Michael H. Salinger, Paul J. Pearson
Publikováno v:
J Cardiol Cases
Patent foramen ovale (PFO) closure is indicated in cryptogenic stroke. Percutaneous PFO closure is both feasible and highly efficacious with low incidence of device-related complications. When complications occur, they are usually discovered within 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab6bb678ea44b68a0c8a772e2dbf09a7
https://europepmc.org/articles/PMC8380948/
https://europepmc.org/articles/PMC8380948/
Autor:
Arshad Yousuf, Nazia Alvi, Ankit Patel, Seban Liu, Vikas Patel, Michael J. Anderson, Samia Qadir, Raju Abraham, Bharat Surani
Publikováno v:
Journal of the American College of Cardiology. 75:2854
Septal occluder devices are used for closure of Secundum Atrial Septal Defect (ASD) and Patent Foramen Ovale (PFO) for patients with stroke from paradoxical emboli. While several complications are reported, the least reported is late endocarditis. 65
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aefdaf717722ec7c04468a7246eba5b3
https://doi.org/10.1016/s0735-1097(20)33481-1
https://doi.org/10.1016/s0735-1097(20)33481-1
Publikováno v:
Catheterization and Cardiovascular Interventions. 86:115-120
The GORE® HELEX® Septal Occluder (HSO: W.L. Gore & Associates; Flagstaff, AZ) is preferentially used at our institution for percutaneous closure of the patent foramen ovale (PFO). Adequate deployment of the device requires capture of three sequenti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbfc945a5fe6cc77efd76b6497e9915f
https://doi.org/10.1002/ccd.25869
https://doi.org/10.1002/ccd.25869
Publikováno v:
Cardiology in the Young. 26:79-83
Children with a secundum atrial septal defect are usually asymptomatic and are referred for elective closure after 3–4 years of age; however, in premature infants with chronic lung disease, bronchopulmonary dysplasia, or pulmonary hypertension, inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54205e18ca70f57ba73cf1969b533556
https://doi.org/10.1017/s1047951114002650
https://doi.org/10.1017/s1047951114002650
Publikováno v:
Catheterization and Cardiovascular Interventions. 84:204-210
Objectives : To describe the effectiveness of the Helex Septal Occluder (HSO) to close multiple atrial septal defects (mASDs). Background : Limited information is available describing closure of mASDs with the HSO. Methods : A total of 28 patients wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35253a0118fc3b5f52a91f95606d1705
https://doi.org/10.1002/ccd.25164
https://doi.org/10.1002/ccd.25164
Autor:
Jake Goble, John F. Rhodes
Publikováno v:
Catheterization and Cardiovascular Interventions. 83:944-952
Objectives Our goal was to summarize the outcome for all subjects evaluated during a prospective clinical study in the United States with the GORE® HELEX® Septal Occluder for transcatheter repair of secundum atrial septal defects (ASD). Background
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35b82b482dca049cb9e5a101aa15f5d1
https://doi.org/10.1002/ccd.24987
https://doi.org/10.1002/ccd.24987
Autor:
Kevin D. Hill, Daniel Forsha, Amanda S. Green, John F. Rhodes, Gregory A. Fleming, Andrew J. Lodge
Publikováno v:
Catheterization and Cardiovascular Interventions. 81:654-659
Objectives: To evaluate feasibility, efficacy, and safety of an approach to atrial septal defect (ASD) occlusion in children ≤20 kg that eliminates cardiac wall erosion risk. Background: Cardiac wall erosion is a potentially catastrophic complicati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9200d841309c2daeb51ef1d9e03960e5
https://doi.org/10.1002/ccd.24500
https://doi.org/10.1002/ccd.24500
Publikováno v:
Journal of Interventional Cardiology. 24:366-372
Background: Ideally, percutaneous, mechanical closure of defects of the atrial septum should completely resolve shunt. To achieve this goal, more information is needed about the factors associated with device failure. Methods: Consecutive patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66808f1aaa083749b7817ad178016448
https://doi.org/10.1111/j.1540-8183.2011.00644.x
https://doi.org/10.1111/j.1540-8183.2011.00644.x